GenMont Biotech Incorporation (3164.TW) TAI
16.25
-0.15(-0.91%)
Currency In TWD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.33B |
| Enterprise Value | 1.34B |
| P/E Ratio | 13.08 |
| PEG Ratio | 0.74 |
| Price/Sales Ratio | 3.58 |
| Price/Book Ratio | 0.46 |
| Enterprise/Revenue | 3.3 |
| Enterprise/EBITDA | 14.46 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.11 |
| Operating Margin | 0.1 |
Management Effectiveness
| Return On Assets | 0.03 |
| Return On Equity | 0.03 |
Income Statement
| Revenue | 401.23M |
| Revenue/Share | 10.82 |
| Gross Profit | 251.63M |
| EBITDA | 124.57M |
| Net Income | 57.2M |
| Diluted EPS | 0.66 |
Balance Sheet
| Total Cash | 456.88M |
| Total Cash/Share | 12.64 |
| Total Debt | 119.74M |
| Total Debt/Equity | 0.09 |
| Current Ratio | 2.77 |
| Book Value Per Share | 38.9 |
Price History
| 52-Week Change | -19.75 |
| 52-Week High | 22.4 |
| 52-Week Low | 16 |
| Moving Average 50 Days | 17.63 |
| Moving Average 200 Days | 18.38 |
Statistics
| Average Volume | 68,443 |
| Shares Outstanding | 86.01M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.8 |
| Trailing Annual Dividend Yield | 4.92 |
| Payout Ratio | 1.54 |
| Last Split Factor | 11:10 |
| Last Split Date | June 15, 2010 |
